Breathe Well Live Well
|
Researchers identify biological pathway that explains why current asthma therapies fail in many cases
News-Medical.net Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease and often don't even significantly alleviate the symptoms. Now … |
View full post on asthma – Google News
|
Asthma and COPD Therapies Market Forecast 2015-2025
PR Newswire (press release) What can be expected from the Asthma and COPD Therapies market? Which areas are going to grow at the fastest rates? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there. |
View full post on asthma – Google News
|
Asthma, COPD Therapies Raise Curtain at Conference
Medscape AMSTERDAM — Personalized medicine will be a key theme here at the European Respiratory Society (ERS) International Congress 2015, especially for complicated diseases like asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung … |
View full post on asthma – Google News
Medscape |
Discovery of Asthma Subtypes Suggests New Therapies
Medscape A new understanding of different subsets of patients with severe allergic asthma may pave the way to developing biologic therapies that effectively target the specific inflammatory responses a particular patient exhibits, a new study suggests. David F … |
View full post on asthma – Google News
News-Medical.net |
Findings reveal new pathway to develop effective treatments and therapies for …
News-Medical.net Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal a new pathway that … |
View full post on asthma – Google News
|
Table 1. Main clinically relevant outcomes to assess asthma therapies
Medscape ACQ, Asthma Control Questionnaire; ACSS, Asthma Control Scoring System; ACT, asthma control test; BAL, Bronchoalveolar lavage; EBC, exhaled breath condensate; FEF, Forced expiratory flow; FENO, fractional exhaled nitric oxide; FEV1, forced expiratory … |
View full post on asthma – Google News
|
Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for …
Satellite PR News (press release) Where's the asthma and COPD therapies market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 335-page report provides 264 tables, charts, and graphs. Discover … |
View full post on asthma – Google News
|
Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for …
PR Newswire (press release) Where's the asthma and COPD therapies market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 335-page report provides 264 tables, charts, and graphs. Discover … |
View full post on asthma – Google News
|
New target identified that can lead to potential therapies for Asthma
Zee News Researchers at the University of California, San Diego School of Medicine, with collaborators in Korea and Scotland, have identified a novel signaling pathway critical to the immune response of cells associated with the initiation of allergic asthma. |
View full post on asthma – Google News
ANINEWS |
New target identified that can lead to potential therapies for Asthma
ANINEWS Specifically, the scientists demonstrated that T helper 2 (Th2) type inflammations in allergic asthma involves dendritic cells (DC), a type of white blood cell, which trigger a reduction in the production of cyclic AMP or cAMP, a key messenger molecule … |
View full post on asthma – Google News